L ately, the biggest topic in the herbal medicine/ dietary supplement arena seems to be the quality of supplements sold on store shelves. This has been an issue of concern and sometimes quite heated debate for a long time, but the flames were fanned in February 2015. The New York Attorney General's office sent "cease and desist" letters to several major retailers that were selling dietary supplements, based on a study showing that a majority of the supplements did not contain what they were labeled as containing. 1 This was no surprise to most pharmacists and other health care practitioners. Problems with quality in the supplement industry have existed as long as the industry, back beyond the snake-oil salesmen in the old West to the times when one could purchase bones of saints or magical amulets to ward off cholera-causing demons. But the result raised quite a few eyebrows because, if we are going to rely on science, then the science needs to be accurate and as clear-cut as possible; and many practitioners and researchers had serious questions about the appropriateness of the sole identification test used in the study -DNA barcoding.
There is no question that DNA barcoding, also called DNA fingerprinting, can be an accurate test for the identification of botanical matter. 2 But like any tool, it must be used properly. The big question is whether the test was used appropriately in the New York study. DNA testing can be appropriate for "whole herb" types of dosage forms, which are dried herbs ground and put into a capsule or combined with excipients and compressed into tablets. However, many herbal products are extracts. DNA barcoding may not be appropriate for those, as United States Pharmacopeia (USP), the nation's standard-setting organization for prescription drug and over-the-counter (OTC) products, explained in their response to the New York situation. 3 The "why" may be most easily explained to patients and consumers with an example from daily life: When you buy a cup of good quality coffee, do you expect to find coffee grounds? Usually not, as that is a clue that preparation of your drink was less than ideal. Coffee is an aqueous extract -a solvent (hot water) comes in contact with botanical matter (coffee beans) and leaches out various chemicals. Herbal extracts prepared into capsules or tablets undergo a great deal more processing (and very often use solvents other than water), but the basic idea is the same. A "perfect extract" should include only extracted chemicals, so that a negative result on a DNA test would be considered reason for celebration rather than condemnation.
However, perfection is rarely achieved. Even extracts with some original botanical material intentionally remaining could present with negative results for DNA tests, if the extract process involved excessive heat or chemicals causing DNA damage. 3 The same is true for heat-processed whole herb preparations. Of course, things are rarely as simple as analogies imply; some herbal medicinal products consist of combinations of extracts and original plant materials and therefore should have positive DNA test results.
Examining the list of various supplements that were tested (echinacea, garlic, ginkgo, ginseng, St. John's wort, saw palmetto, valerian root), it is very likely that both whole herb products and extract products were included in the New York study. Knowing exactly what types were tested is necessary to truly interpret and understand those results and the magnitude of the quality problem. To further highlight the inadequacies of the science used, USP has existing standards for identification and quality testing of echinacea, garlic, ginkgo, ginseng, St. John's wort, and saw palmetto products; none of those monograph standards currently utilize DNA methods.
Maybe we should be thanking New York Attorney General Schneiderman and the researcher, Dr. Schulte, for drawing attention to an often overlooked problem.
1 Despite limitations in regard to primary ingredient identification, the New York study did provide some very valuable information on the supplements. Nonactive fillers have legitimate uses in extract products, so it is perhaps not such a surprise or problem that they were present. But "houseplant"? 1 Granted, that is a vague term, but it is highly unlikely that any plants commonly used for household decoration would either have medicinal value or be suitable for use as a nonactive filler. Multiple products were found to contain wheat matter that was undisclosed on the labeling or, worse, was found on products specifically labeled as gluten-free.
1 Those small amounts may indeed be a small matter for individuals going gluten-free by choice, but they pose much more serious consequences for patients with celiac disease or gluten intolerance. Other contaminants or undisclosed ingredients included some that could be unsafe for individuals with severe allergies, such as beans, wild carrot (which has cross-reactivity with celery), and asparagus (cross-reactivity with onions).
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Other reports of quality concerns are based on science that is more sound. Many severe adverse events with herbal medications have been methodically traced to accidental or purposeful substitution of toxic plants for the intended herbs. A well-known series of cases of chronic kidney disease in young women in Belgium in the early 1990s resulted from substitution of Aristolochia fangchi for the herb Stephania tetrandra. 5 Proof of low quality, whether through contamination or insufficient potency, abounds in academic studies and reports from consumer organizations. [6] [7] [8] One of the reasons the United States currently has an abundance of poor quality dietary supplements can be found in the history of the implementation of DSHEA, the Dietary Supplement Health and Education Act of 1994. In the interest of brevity, here is a student version of the history of DSHEA: Not the most elegant of explanations, but that is the gist of DSHEA's background. The product quality problems we have today stem in large part from the lengthy delay in the development and implementation of good manufacturing practices (GMPs) for dietary supplements. DSHEA allowed the US Food and Drug Administration (FDA) to create GMPs for dietary supplements (DS-GMPs); once written, the proposed GMPs were passed from government office to government office and never approved. Some dietary supplement manufacturer trade associations, such as the National Nutritional Foods Association (now the Natural Products Association), developed their own GMPs, which were followed on a voluntary basis. Other large companies used food GMPs or drug GMPs, or they created their own guidelines for quality. The lack of official regulation left a void that was a goldmine of opportunity for unscrupulous, small, often fly-by-night companies that made and promoted extremely poor quality products. If these companies were shut down by the FDA for egregious quality issues (usually adulteration) or by the Federal Trade Commission for violations of advertising regulations, they would simply move on and reopen elsewhere. 9 In 2007, the proposed regulations were discarded and new DS-GMPs were proposed, approved, and became effective in phases. 10 Large companies had to abide by the standards by June 2008, whereas companies with fewer than 20 employees had to meet the standards by June 2010; companies are allowed to request exemptions. 11 The groups within the FDA with the responsibility to provide oversight and guidance to supplement manufacturers are not funded nor staffed to the same extent as those responsible for monitoring prescription drug manufacturers. The end result is still an environment in which compliance with the law is mostly voluntary and often overlooked.
In this environment, misinformation and marketing lies about supplements are still plentiful; even thoughtful patients find it almost impossible to get reliable information in order to make good decisions. The majority of consumers believe that supplements are "FDA-approved" just like prescription and OTC drugs, so they never give a thought to quality. 10 How can we protect patients in this milieu?
Right now, the best we can do for patients who choose to use herbs or nonherbal dietary supplements (either with or against our efficacy recommendations) is to provide education on the problem of quality and practical guidance on how to navigate store shelves or online markets. After getting appropriate information about choosing a supplement, the selection of a particular brand of that supplement should be governed by the following:
Does it have the USP Verified seal? Manufacturers who choose to participate in USP's Dietary Supplement Verification Program must meet GMPs and use additional testing to prove identity, potency, and quality that meet USP's monograph standards.
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There are several manufacturers whose products can carry the gold USP Verified seal on multivitamins, single vitamins, minerals, fish oil, melatonin, coenzyme Q10, glucosamine, and chondroitin. Unfortunately, despite the existence of monograph standards for over 50 botanicals, no herbal medicine products on the market are manufactured to USP standards.
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Has it been tested by a third-party laboratory? ConsumerLab tests products that are purchased from store shelves and will also test products at the request (and payment) of the manufacturer. Not all supplements have been tested and not all brands of tested supplements are included in the ratings. Results are available at its website (www.consumerlab.com); full information is available only by subscription (currently $36 per year). Consumers Union, the publisher of Consumer Reports, has also tested supplements for quality on an occasional basis. To access that information, users need to purchase an individual issue of the magazine or subscribe to access online content.
In the past, a very last resort in guidance, and always one less supportable, was a recommendation to purchase only from major manufacturers that also produce OTC drug products. The rationale was that these companies were used to GMP requirements for making OTC drugs and therefore were more likely to be cognizant of the overall need for quality and attentive to quality assurance and control. However, the results of the New York study, flawed as it was in some aspects, really kicked the legs out from under that reasoning.
Until this quality situation resolves to a meaningful extent, which may entail an entirely new method of regulation, any recommendations by health care professionals to patients should generally be restricted to verified or tested products. There is a great deal of variability in hospital formulary policies for dietary supplement use, with some allowing none and others allowing use of home-supplied supplements only. 13 Among hospitals that do allow dietary supplements in their drug formularies, inclusion should be restricted solely to brands that are USP Verified or third-party tested. That may mean that patients may not be able to use supplements with the potential for benefit, but currently, it is the only reasonable measure to ensure safety in terms of quality.
